Pulsed Radiofrequency Therapy for Hand OsteoArthritis Pain
Launched by LEIDEN UNIVERSITY MEDICAL CENTER · Jan 31, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new treatment option for people who suffer from hand osteoarthritis pain. Osteoarthritis is a condition that causes joint pain and stiffness, and it can be challenging to find effective treatments because patients may experience different types of pain. The trial will specifically evaluate the use of pulsed radiofrequency therapy, a non-invasive technique that sends electrical pulses to help reduce pain in the hands.
To participate in this trial, individuals need to be between 18 and 80 years old and have been diagnosed with hand osteoarthritis, experiencing significant pain. However, certain conditions may exclude someone from joining, such as having other inflammatory diseases, neurological disorders, or recent surgeries. Participants will receive this new treatment and will be monitored for its effects on their pain levels. This study is currently recruiting participants, and it aims to help find better ways to manage hand osteoarthritis pain for those affected.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-80
- • Hand osteoarthritis according to the ACR criteria
- • Hand pain of at least 30mm on a 100mm VAS
- • Chronic hand pain
- Exclusion Criteria:
- • Known inflammatory rheumatic diseases
- • Psoriasis
- • Seropositivity for rheumatoid factor of anti-CCP antibodies
- • No understanding of the Dutch language
- • Fibromyalgia (Following the ACR 2011 classification criteria)
- • Neurological disorders interfering with pain perception and measurements
- • Carpal tunnel syndrome interfering with pain perception and measurements
- • History of chemo- and/or radiotherapy
- • Spinal surgery or spinal trauma with lasting complaints interfering with pain perception and measurements
- • Cognitive impairment or psychiatric conditions interfering with pain perception and measurements
- • Pregnancy or breast-feeding
- • Eye surgery for glaucoma or keratoconus or other surgery of the cornea in the three preceding months
- • Presence of an implantable cardioverter-defibrillator (ICD), neurostimulator or pacemaker
- • Metal implants in the hand, arm, shoulder or neck of the side that is to be treated
About Leiden University Medical Center
Leiden University Medical Center (LUMC) is a prominent academic medical center located in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and high-quality patient care. As a clinical trial sponsor, LUMC focuses on translating scientific discoveries into effective therapies, fostering collaborations between researchers, clinicians, and industry partners. The center is dedicated to conducting rigorous clinical studies across various medical fields, ensuring adherence to ethical standards and regulatory requirements while prioritizing patient safety and outcomes. Through its multidisciplinary approach, LUMC aims to contribute significantly to the understanding and treatment of complex health conditions, driving progress in personalized medicine and improving global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leiden, Zuid Holland, Netherlands
Patients applied
Trial Officials
Margreet Kloppenburg, Prof. Dr.
Principal Investigator
LUMC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials